Cholesterol, cancer, and rebooting a treatment for athlete’s foot-Reference-Cited by-同舟云学术

Cholesterol, cancer, and rebooting a treatment for athlete’s foot

Published:2018-04-18 Issue:437 Volume:10 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Chua Ngee Kiat¹^ORCID,Coates Hudson W.¹,Brown Andrew J.¹^ORCID

Affiliation:

1. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia.

Abstract

A key enzyme in cholesterol synthesis is placed firmly on the oncogenic map and demonstrated to be a potential therapeutic target in liver cancer by repurposing a common antifungal agent (Liu et al ., this issue).

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference10 articles.

1. The Role of Cholesterol in the Pathogenesis of NASH

2. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target

3. Cholesterol-Dependent Degradation of Squalene Monooxygenase, a Control Point in Cholesterol Synthesis beyond HMG-CoA Reductase

4. Cellular cholesterol trafficking and compartmentalization

5. Cholesterol Metabolism and Prostate Cancer Lethality

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinoma;Heliyon;2024-03

2. Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor;Cellular Oncology;2022-07-22

3. AGR2-induced cholesterol synthesis drives lovastatin resistance that is overcome by combination therapy with allicin;Acta Pharmacologica Sinica;2022-04-22

4. Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?;Frontiers in Cell and Developmental Biology;2021-03-19

5. Chronic Disruption of the Late Cholesterol Synthesis Leads to Female-Prevalent Liver Cancer;Cancers;2020-11-09